Proximal injection near the injury site is preferred for musculoskeletal applications because it appears to increase local tissue concentration
Safety, Pharmacology, and Regulatory Science : Studying how AOD 9604 is absorbed, distributed, metabolized, and excreted in the body, as well as comparing its safety profile with that of full-length growth hormone
Syringe Units = Volume to Draw (mL) 100 = 0.1 mL 100 = 10 units BPC-157 Dosing Profile (10 mg Vial / 2 mL BAC Water) 250 mcg Dose: Draw 5 units (0.05 mL)
Most patients receive training from their GP practice nurse before being deemed competent for self-administration
CJC-1295 without DAC: Shorter half-life, requires more frequent dosing, but gives more control over timing
Considerations and Future Research While the initial research on BPC-157 is promising, more studies are needed to fully understand its long-term effects and safety profile